ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Idiopathic Portal Vein Thrombosis: Endovascular Intervention Leads the Way to Recanalization.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundData on treating idiopathic portal vein thrombosis (IPVT)-via anticoagulation (AC), systemic thrombolysis (ST), endovascular intervention (EVI), and surgery-are limited, despite the potentially severe clinical implications of this condition. This study aims to compare treatment outcomes and evaluate the prognosis.MethodsA retrospective analysis of 77 IPVT patients was conducted. Patients were categorized according to their treatment modalities, and their demographics, clinical features, prognoses, and risk factors were analyzed. The primary endpoint was the radiological complete recanalization (CR) rate; secondary endpoints were clinical portal hypertension (CPH) incidence and overall mortality.ResultsAmong the 77 patients with IPVT included in this study, 26 received AC, 23 EVI, 17 ST, and 11 surgery. During follow-up, the overall CR rate was 23.4%, CPH incidence 14.3%, and mortality 7.8%. Patients treated with EVI had a significantly higher CR rate than AC patients (HR: 0.214, 95%CI: 0.058 - 0.795,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.